0001209191-22-010985.txt : 20220217 0001209191-22-010985.hdr.sgml : 20220217 20220217182651 ACCESSION NUMBER: 0001209191-22-010985 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220215 FILED AS OF DATE: 20220217 DATE AS OF CHANGE: 20220217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harrington-Smith Kristen CENTRAL INDEX KEY: 0001894310 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39866 FILM NUMBER: 22650003 MAIL ADDRESS: STREET 1: C/O IMMUNOGEN, INC. STREET 2: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: eFFECTOR Therapeutics, Inc. CENTRAL INDEX KEY: 0001828522 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 853306396 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 142 NORTH CEDROS AVENUE, SUITE B CITY: SOLANA BEACH STATE: CA ZIP: 92075 BUSINESS PHONE: (858) 925-8215 MAIL ADDRESS: STREET 1: 142 NORTH CEDROS AVENUE, SUITE B CITY: SOLANA BEACH STATE: CA ZIP: 92075 FORMER COMPANY: FORMER CONFORMED NAME: Locust Walk Acquisition Corp. DATE OF NAME CHANGE: 20201015 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-15 0 0001828522 eFFECTOR Therapeutics, Inc. EFTR 0001894310 Harrington-Smith Kristen C/O EFFECTOR THERAPEUTICS, INC. 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 1 0 0 0 Stock Option (Right to Buy) 4.61 2022-02-15 4 A 0 40000 0.00 A 2032-02-14 Common Stock 40000 40000 D The shares subject to the option will vest in substantially equal monthly installments over three years, commencing on February 15, 2022, subject to the Reporting Person's continued service with the Issuer through each vesting date. /s/ Michael Byrnes, Attorney-in-Fact for Kristen Harrington-Smith 2022-02-17